Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
52 studies found for:    male reproductive health | eunice kennedy
Show Display Options
Rank Status Study
21 Completed
Has Results
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
Condition: Polycystic Ovary Syndrome
Intervention:
22 Completed Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men
Condition: Contraception
Interventions: Drug: Testosterone;   Drug: Nestorone®
23 Completed Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Conditions: Hyperandrogenemia;   Polycystic Ovary Syndrome (PCOS)
Interventions: Drug: estrace;   Drug: Progesterone
24 Completed Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: Flutamide;   Drug: Progesterone;   Drug: estrace
25 Recruiting Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation
Conditions: Hyperandrogenemia;   Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Dexamethasone;   Drug: Cortrosyn
26 Completed Male Hormonal Contraceptive Development-ACY-5
Condition: Contraception
Interventions: Drug: Acyline;   Drug: Testosterone Gel;   Drug: Depo-Medroxyprogesterone
27 Unknown  Effect of Metformin on Sensitivity of the Gonadotropin-releasing Hormone (GnRH) Pulse Generator to Suppression by Estradiol and Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: Metformin;   Drug: Progesterone;   Drug: estrace
28 Completed Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men
Condition: Healthy
Interventions: Drug: Nestorone® /testosterone gel;   Drug: Testosterone only gel
29 Completed Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
Conditions: Contraception;   Hypogonadism
Interventions: Drug: Oral Testosterone;   Drug: Leuprolide (Lupron);   Drug: Dutasteride
30 Completed Stage Matched Intervention to Increase Dual Method Use
Conditions: Contraception;   Sexually Transmitted Diseases;   Pregnancy
Interventions: Behavioral: Individualized Intervention;   Behavioral: Computer-based contraceptive information
31 Unknown  Contraceptive Awareness and Reproductive Education
Conditions: Contraception;   Sexually Transmitted Diseases;   Pregnancy
Interventions: Behavioral: Motivational Interviewing;   Other: Didactic Educational Counseling
32 Completed Steroid Therapy in Autoimmune Premature Ovarian Failure
Conditions: Autoimmune Disease;   Infertility;   Premature Ovarian Failure
Intervention:
33 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone
34 Unknown  Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
Conditions: Endometriosis;   Dysmenorrhea;   Dyspareunia
Interventions: Drug: Norethindrone Acetate (NA);   Drug: GnRH Agonist (Lupron Depot)
35 Completed Mediators of Abnormal Reproductive Function in Obesity (MARO)
Conditions: Infertility, Female;   Obesity
Interventions: Other: Microdialysis;   Dietary Supplement: Vascepa - Fish Oil;   Drug: Aspirin;   Drug: Pioglitazone
36 Completed
Has Results
PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
Condition: Healthy
Interventions: Drug: Testosterone gel;   Drug: Dutasteride;   Drug: Depo-Medroxyprogesterone (DMPA);   Other: Placebo Testosterone gel;   Other: Placebo dutasteride;   Other: Placebo DMPA
37 Completed Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
Condition: Contraception
Interventions: Drug: Acyline;   Drug: Testosterone Gel;   Drug: Depo-Medroxyprogesterone
38 Completed
Has Results
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Condition: Healthy Males
Interventions: Drug: Acyline;   Other: placebo hCG (no active ingredient);   Drug: hCG (human chorionic gonadotropin);   Drug: Testosterone gel
39 Completed A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)
Condition: Contraception
Interventions: Drug: levonorgestrel patch with BMI 32 kg/m2 to <40 kg/m2;   Drug: levonorgestrel patch with BMI <32 kg/m2
40 Completed
Has Results
Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®
Condition: Pregnancy
Interventions: Drug: C31G;   Drug: nonoxynol-9 (N-9)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.